GUSELKUMAB PROVIDES SUSTAINED IMPROVEMENTS IN WORK PRODUCTIVITY AND DAILY ACTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 2 YEARS OF DISCOVER-2

被引：0
|
作者：
Curtis, J. [1 ]
Mcinnes, I. [2 ]
Rahman, P. [3 ]
Gladman, D. D. [4 ,5 ]
Yang, F. [6 ]
Peterson, S. [6 ]
Kollmeier, A. [7 ]
Shiff, N. [6 ,8 ]
Han, C. [9 ]
Shawi, M. [10 ]
Tillett, W. [11 ]
Mease, P. J. [12 ,13 ]
机构：
[1] Univ Alabama Birmingham, Dept Med Immunol & Rheumatol, Birmingham, AL USA
[2] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland
[3] Mem Univ Newfoundland, Craig L Dobbin Genet Res Ctr, St John, NF, Canada
[4] Toronto Western Hosp, Schroeder Atrhiritis Inst, Dept Med, Ctr Prognosis Studies Rheumat Dis, Toronto, ON, Canada
[5] Krebmil, Res Inst, Toronto, ON, Canada
[6] Janssen Global Serv LLC, Immunol, Horsham, PA USA
[7] Janssen Res & Dev LLC, Immunol, San Diego, CA USA
[8] Univ Saskatchewan, Dept Community Hlth & Epidemiol, Coll Med, Saskatoon, SK, Canada
[9] Janssen Res & Dev LLC, Immunol, Spring House, PA USA
[10] Janssen Pharmaceut Companies Johnson Johnson, Immunol Global Med Affairs, Horsham, PA USA
[11] Royal Natl Hosp Rheumat Dis, Dept Pharm Pharmacol, Ctr Therapeut Innovat, Bath, Avon, England
[12] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[13] Univ Washington, Dept Rheumatol Res, Sch Med, Seattle, WA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.1366
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0888
引用
收藏
页码：1568 / 1569
页数：2
相关论文
共 50 条
  • [41] Guselkumab (TREMFYA®) Maintains Resolution of Dactylitis and Enthesitis in Patients with Active Psoriatic Arthritis: Results Through 2 Years from a Phase 3 Study
    Rahman, Proton
    McInnes, Iain
    Deodhar, Atul
    Schett, Georg
    Mease, Philip
    Shawi, May
    Cua, Daniel
    Sherlock, Jonathan
    Kollmeier, Alexa
    Xu, Xie
    Jiang, Yusang
    Sheng, Shihong
    Ritchlin, Christopher
    McGonagle, Dennis
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2757 - 2760
  • [42] Ixekizumab Provides Improvements through 52 Weeks in Physical Function, Quality of Life, and Work Productivity in Biologic DiseaseModifying Antirheumatic Drug-Naive Patients with Active Psoriatic Arthritis
    Gottlieb, Alice
    Husni, Elaine
    Shuler, Catherine
    Burge, Russel
    Lin, Chen-Yen
    Lee, Chin
    Gladman, Dafna
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 924 - 925
  • [43] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS (PSA) THROUGH 3 YEARS: EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIAL
    Hall, S.
    Mease, P.
    Kavanaugh, A.
    Reimold, A.
    Tahir, H.
    Rech, J.
    Geusens, P.
    Pascale, P.
    Delicha, E.
    Pricop, L.
    Mpofu, S.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 37 - 38
  • [44] Sustained Improvements in Physical Function, Quality of Life, and Work Productivity after Ixekizumab Therapy in Patients with Active Psoriatic Arthritis: 3-Year Results
    Fleischmann, Roy
    Chandran, Vinod
    Lespessailles, Eric
    Birt, Julie
    Benichou, Olivier
    Erickson, Janelle
    Shuler, Catherine
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [45] SECUKINUMAB SUSTAINS IMPROVEMENTS IN SIGNS AND SYMPTOMS IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH 2 YEARS (FUTURE 4)
    Everding, A.
    Kivitz, A.
    Nash, P.
    Tahir, H.
    Pellet, P.
    Wang Yi
    Pricop, L.
    Abrams, K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 727 - 728
  • [46] CHANGES IN SERUM CYTOKINES AND COLLAGEN PROTEINS CORRELATE WITH DURABILITY OF GUSELKUMAB EFFICACY AND CONTINUED DISEASE IMPROVEMENT THROUGH 2 YEARS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Siebert, S.
    Schett, G.
    Raychaudhuri, S. P.
    Guma, M.
    Chen, W.
    Gao, S.
    Chakravarty, S. D.
    Shawi, M.
    Rahman, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1763 - 1764
  • [47] Changes in Serum Cytokines and Collagen Proteins Correlate with Durability of Guselkumab Efficacy and Continued Disease Improvement Through 2 Years in Patients with Active Psoriatic Arthritis
    Siebert, Stefan
    Schett, Georg
    Raychaudhuri, Siba
    Guma, Monica
    Chen, Warner
    Gao, Sheng
    Chakravarty, Soumya
    Shawi, May
    Rahman, Proton
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2787 - 2789
  • [48] Patient Characteristics and Clinical Features Associate with Health-Related Quality of Life in Bio-naive Patients with Active Psoriatic Arthritis Through Week 24 of the DISCOVER-2 Study
    Curtis, Jeffrey
    McInnes, Iain
    Rahman, Proton
    Gladman, Dafna
    Yang, Feifei
    Peterson, Steven
    Agarwal, Prasheen
    Kollmeier, Alexa
    Hsia, Elizabeth
    Han, Chenglong
    Shawi, May
    Tillett, William
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3785 - 3787
  • [49] THE EFFECT OF GUSELKUMAB ON DACTYLITIS: RESULTS FROM A PHASE 2 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Gladman, D.
    Boehncke, W. -H.
    Gottlieb, A. B.
    Helliwell, P.
    Nash, P.
    Xu, X. L.
    Xu, S.
    Wang, Y.
    Hsia, E. C.
    Karyekar, C. S.
    Deodhar, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1025 - 1026
  • [50] THE EFFECT OF GUSELKUMAB ON ENTHESITIS: RESULTS FROM A PHASE 2 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Helliwell, Philip
    Gottlieb, Alice B.
    Deodhar, Atul
    Boehncke, Wolf-Henning
    McGonagle, Dennis
    Lawson, Fabio L.
    Xu, Stephen
    Hsia, Elizabeth
    Karyekar, Chetan
    Mease, Philip
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S65 - S66
12345